Waiting
Login processing...

Trial ends in Request Full Access Tell Your Colleague About Jove
Journal / Medicine / The WATCHMAN Left Atrial Appendage Closure Device …
JoVE Journal
Medicine

This content is Free Access.

JoVE Journal Medicine
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
TRUE Gene Silencing: Screening of a Heptamer-type Small Guide RNA Library for Potential Cancer Therapeutic Agents
Journal (Medicine)
TRUE Gene Silencing: Screening of a Heptamer-type Small Guide RNA Library for Potential Cancer Therapeutic Agents
Establishing In Situ Closed Circuit Perfusion of Lower Abdominal Organs and Hind Limbs in Mice
Journal (Medicine)
Establishing In Situ Closed Circuit Perfusion of Lower Abdominal Organs and Hind Limbs in Mice
 

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Article DOI: 10.3791/3671-v • 23:34 min • February 28th, 2012
February 28th, 2012 •
1, 1, 1, 1, 1, 1
1University of Leipzig Heart Center

Chapters

Summary
Automatic Translation

The accompanying video describes a procedure for percutaneous placement of the WATCHMAN Left Atrial Appendage (LAA) Device. The WATCHMAN is a nitinol device designed to be permanently implanted at, or slightly distal to, the opening of the left atrial appendage (LAA) to trap blood clots before they exit the LAA, preventing thromboembolic stroke.

Tags

WATCHMAN Left Atrial Appendage Closure Device Atrial Fibrillation Cardiac Arrhythmia Ischemic Stroke Rate Control Rhythm Control Prevention Of Stroke Pharmacological Agents Beta-blockers Antiarrhythmic Drugs Amiodarone Electrical Cardioversion Ablation Therapy Hospitalization Rates Serious Adverse Effects Mortality Structural Heart Defects
Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter